Eye Health News and Research

Latest Eye Health News and Research

Nanoparticle carriers expand the effectiveness of gene therapies for human eye diseases

NIBIB-funded researchers have created nanoparticles for successful gene therapy of a mouse model of macular degeneration.

15 Aug 2020

Retrieving memories is an active process that can bias and distort memories

Adopting a third-person, observer point of view when recalling your past activates different parts of your brain than recalling a memory seen through your own eyes, according to a new paper.

14 Aug 2020

Distance between options influences diners to pick more planet-friendly meals

Researchers have identified the optimal dish positions to help “nudge” diners into picking more planet-friendly meals in cafeterias.

13 Aug 2020

New cell injection technique could help reverse forms of vision loss

University of Toronto Engineering researchers have developed a new method of injecting healthy cells into damaged eyes.

13 Aug 2020

A software-based on AI helps assess the progression of geographic atrophy

A software-based on artificial intelligence (AI), which was developed by researchers at the Eye Clinic of the University Hospital Bonn, Stanford University and University of Utah, enables the precise assessment of the progression of geographic atrophy (GA), a disease of the light sensitive retina caused by age-related macular degeneration (AMD).

13 Aug 2020

Choosing the best milk fortifiers can lead to improved health outcomes in premature babies

More than 380,000 babies are born prematurely in the United States each year, according to the March of Dimes.

13 Aug 2020

SPT enzyme can be used as metabolically responsive “switch” to slow tumor growth

The enzyme serine palmitoyl-transferase can be used as a metabolically responsive "switch" that decreases tumor growth, according to a new study by a team of San Diego scientists, who published their findings Aug. 12 in the journal Nature.

12 Aug 2020

Study reveals multicellular physiology in Myxococcus xanthus bacterium

Research by INRS (Institut National de la Recherche Scientifique) Professor Salim Timo Islam and his PhD student Fares Saïdi has recently revealed that multicellular physiology in the social bacterium Myxococcus xanthus

12 Aug 2020

Multifocal contact lenses reduce worsening nearsightedness in children

Children wearing multifocal contact lenses had slower progression of their myopia, according to results from a clinical trial funded by the National Eye Institute, part of the National Institutes of Health.

11 Aug 2020

Exclusive: Over 900 health workers have died of COVID-19. And the toll is rising

More than 900 front-line health care workers have died of COVID-19, according to an interactive database unveiled Wednesday by The Guardian and KHN. Lost on the Frontline is a partnership between the two newsrooms that aims to count, verify and memorialize every U.S. health care worker who dies during the pandemic.

11 Aug 2020

Pupil size predicts death and hospital readmission in patients with heart failure

Pupil size predicts death and hospital readmission in patients with heart failure, according to research published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).1

11 Aug 2020

Novel coronavirus does not directly damage taste bud cells, UGA study shows

A new study from the Regenerative Bioscience Center at the University of Georgia is the first to suggest that COVID-19 does not directly damage taste bud cells.

10 Aug 2020

Gene therapy to the inner retina prevents blindness in mouse model of CLN3 Batten disease

Gene therapy to the inner retina prevented blindness in a mouse model of the neuro-degenerative disorder CLN3 Batten disease.

10 Aug 2020

Scientists identify new treatment targets for blinding retinal disease

When the eye isn't getting enough oxygen in the face of common conditions like premature birth or diabetes, it sets in motion a state of frenzied energy production that can ultimately result in blindness, and now scientists have identified new points where they may be able to calm the frenzy and instead enable recovery

10 Aug 2020

Encouraging results from Phase I NovaVax SARS-CoV-2 nanoparticle vaccine trial

NVX-CoV2373, a recombinant nanoparticle vaccine developed by Novavax and manufactured at Emergent Biosolutions, was found to be well tolerated and immunogenic – inducing T-cell response and neutralization antibodies four-fold higher than the mean observed in hospitalized coronavirus disease (COVID-19) patients, shows a recent study available on the medRxiv* preprint server.

9 Aug 2020

Large-scale analysis of Alport syndrome reveals the effectiveness of existing treatments

A large-scale analysis of the clinical characteristics of Alport syndrome in Japanese patients has revealed that the effectiveness of existing treatment with ACE inhibitors and/or angiotensin receptor blockers (RAS inhibitors) varies depending on the type of mutation in the syndrome's causal gene (COL4A5).

7 Aug 2020